{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:46:17Z","timestamp":1793108777016,"version":"4.5.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["neuromodulationjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromodulation: Technology at the Neural Interface"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.neurom.2021.10.021","type":"journal-article","created":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T17:09:24Z","timestamp":1641229764000},"page":"450-460","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Comparative Effectiveness of Transcutaneous Auricular Vagus Nerve Stimulation vs Citalopram for Major Depressive Disorder: A Randomized Trial"],"prefix":"10.1016","volume":"25","author":[{"given":"Shaoyuan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peijing","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guixing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobing","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiting","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sierra","family":"Hodges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Vangel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurom.2021.10.021_bib1","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1001\/jamapsychiatry.2017.4602","article-title":"Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States","volume":"75","author":"Hasin","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.neurom.2021.10.021_bib2","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12955-014-0188-y","article-title":"Importance of remission and residual somatic symptoms in health-related quality of life among outpatients with major depressive disorder: a cross-sectional study","volume":"12","author":"Woo","year":"2014","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.neurom.2021.10.021_bib3","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4088\/JCP.14m09298","article-title":"The economic burden of adults with major depressive disorder in the United States (2005 and 2010)","volume":"76","author":"Greenberg","year":"2015","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.neurom.2021.10.021_bib4","series-title":"Treatment of Depression: Bridging the 21st Century","first-page":"151","article-title":"Physical treatments in psychiatry","author":"Sackeim","year":"2001"},{"key":"10.1016\/j.neurom.2021.10.021_bib5","series-title":"Vagus Nerve Stimulation","first-page":"68","article-title":"Potential mechanisms of action of vagus nerve stimulation for depression","author":"George","year":"2003"},{"key":"10.1016\/j.neurom.2021.10.021_bib6","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/sj.npp.1301082","article-title":"VNS therapy in treatment-resistant depression: clinical evidence and putative neurobiological mechanisms","volume":"31","author":"Nemeroff","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neurom.2021.10.021_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2008.02.012","article-title":"Safety and efficacy of vagus nerve stimulation in treatment-resistant depression. A systematic review","volume":"110","author":"Daban","year":"2008","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.neurom.2021.10.021_bib8","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.5694\/mja12.10509","article-title":"Non-pharmacological biological treatment approaches to difficult-to-treat depression","volume":"199","author":"Fitzgerald","year":"2013","journal-title":"Med J Aust"},{"key":"10.1016\/j.neurom.2021.10.021_bib9","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/s13311-017-0537-8","article-title":"Vagal nerve stimulation for treatment-resistant depression","volume":"14","author":"Carreno","year":"2017","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neurom.2021.10.021_bib10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3389\/fnins.2018.00239","article-title":"Vagus nerve stimulation (VNS) and other augmentation strategies for therapy-resistant depression (TRD): review of the evidence and clinical advice for use","volume":"12","author":"Mu\u00fcller","year":"2018","journal-title":"Front Neurosci"},{"key":"10.1016\/j.neurom.2021.10.021_bib11","doi-asserted-by":"crossref","first-page":"152156","DOI":"10.1016\/j.comppsych.2019.152156","article-title":"Vagus nerve stimulation (VNS) therapy in patients with treatment resistant depression: a systematic review and meta-analysis","volume":"98","author":"Bottomley","year":"2019","journal-title":"Compr Psychiatry"},{"key":"10.1016\/j.neurom.2021.10.021_bib12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/ca.1089","article-title":"The nerve supply of the human auricle","volume":"15","author":"Peuker","year":"2002","journal-title":"Clin Anat"},{"key":"10.1016\/j.neurom.2021.10.021_bib13","first-page":"588","article-title":"The anatomical basis for transcutaneous auricular vagus nerve stimulation","volume":"236","author":"Butt","year":"2020","journal-title":"J\u00a0Anat"},{"key":"10.1016\/j.neurom.2021.10.021_bib14","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1590\/0004-282X20140061","article-title":"Transcutaneous vagus and trigeminal nerve stimulation for neuropsychiatric disorders: a systematic review","volume":"72","author":"Shiozawa","year":"2014","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.neurom.2021.10.021_bib15","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1111\/ene.12629","article-title":"Surgically implanted and non-invasive vagus nerve stimulation: a review of efficacy, safety and tolerability","volume":"22","author":"Ben-Menachem","year":"2015","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurom.2021.10.021_bib16","doi-asserted-by":"crossref","first-page":"854","DOI":"10.3389\/fnins.2019.00854","article-title":"Current directions in the auricular vagus nerve stimulation I\u2014a physiological perspective","volume":"13","author":"Kaniusas","year":"2019","journal-title":"Front Neurosci"},{"key":"10.1016\/j.neurom.2021.10.021_bib17","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/WNP.0000000000000576","article-title":"Transcutaneous auricular vagus nerve stimulation","volume":"36","author":"Ellrich","year":"2019","journal-title":"J\u00a0Clin Neurophysiol"},{"key":"10.1016\/j.neurom.2021.10.021_bib18","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.2147\/NDT.S136065","article-title":"The potential role of vagus-nerve stimulation in the treatment of HIV-associated depression: a review of literature","volume":"13","author":"Nicholson","year":"2017","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.neurom.2021.10.021_bib19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.brainresbull.2019.11.011","article-title":"Vagal nerve stimulation as a promising tool in the improvement of cognitive disorders","volume":"155","author":"Broncel","year":"2020","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.neurom.2021.10.021_bib20","doi-asserted-by":"crossref","first-page":"101971","DOI":"10.1016\/j.nicl.2019.101971","article-title":"Transcutaneous auricular vagus nerve stimulation at 1Hz modulates locus coeruleus activity and resting state functional connectivity in patients with migraine: an fMRI study","volume":"24","author":"Zhang","year":"2019","journal-title":"Neuroimage Clin"},{"key":"10.1016\/j.neurom.2021.10.021_bib21","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1136\/rapm-2020-102088","article-title":"Transcutaneous auricular vagus nerve stimulation (taVNS) for migraine: an fMRI study","volume":"46","author":"Zhang","year":"2021","journal-title":"Reg Anesth Pain Med"},{"key":"10.1016\/j.neurom.2021.10.021_bib22","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fpsyt.2018.00020","article-title":"Treating depression with transcutaneous auricular vagus nerve stimulation: state of the art and future perspectives","volume":"9","author":"Kong","year":"2018","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.neurom.2021.10.021_bib23","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.biopsych.2015.11.016","article-title":"The allure of transcutaneous vagus nerve stimulation as a novel therapeutic modality","volume":"79","author":"Carreno","year":"2016","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.neurom.2021.10.021_bib24","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00702-012-0908-6","article-title":"Auricular transcutaneous electrical nerve stimulation in depressed patients: a randomized controlled pilot study","volume":"120","author":"Hein","year":"2013","journal-title":"J\u00a0Neural Transm (Vienna)"},{"key":"10.1016\/j.neurom.2021.10.021_bib25","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jad.2016.02.031","article-title":"Effect of transcutaneous auricular vagus nerve stimulation on major depressive disorder: a nonrandomized controlled pilot study","volume":"195","author":"Rong","year":"2016","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.neurom.2021.10.021_bib26","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.brs.2016.02.001","article-title":"Transcutaneous vagus nerve stimulation (taVNS) for major depressive disorder: an open label proof-of-concept trial","volume":"9","author":"Trevizol","year":"2016","journal-title":"Brain Stimul"},{"key":"10.1016\/j.neurom.2021.10.021_bib27","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3389\/fnins.2020.00284","article-title":"Critical review of transcutaneous vagus nerve stimulation: challenges for translation to clinical practice","volume":"14","author":"Yap","year":"2020","journal-title":"Front Neurosci"},{"key":"10.1016\/j.neurom.2021.10.021_bib28","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12974-020-01732-5","article-title":"Neural networks and the anti-inflammatory effect of transcutaneous auricular vagus nerve stimulation in depression","volume":"17","author":"Liu","year":"2020","journal-title":"J\u00a0Neuroinflammation"},{"key":"10.1016\/j.neurom.2021.10.021_bib29","series-title":"The Neuroscience of Depression: Features, Diagnosis, and Treatment","first-page":"469","article-title":"Transcutaneous auricular vagus nerve stimulation in the treatment of depression","author":"Kong","year":"2021"},{"key":"10.1016\/j.neurom.2021.10.021_bib30","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/ner.13366","article-title":"Transcutaneous vagal nerve stimulation in treatment-resistant depression: a feasibility study","volume":"25","author":"Evensen","year":"2022","journal-title":"Neuromodulation"},{"key":"10.1016\/j.neurom.2021.10.021_bib31","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1017\/S0033291719003490","article-title":"Effects of acute transcutaneous vagus nerve stimulation on emotion recognition in adolescent depression","volume":"51","author":"Koenig","year":"2021","journal-title":"Psychol Med"},{"key":"10.1016\/j.neurom.2021.10.021_bib32","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.biopsych.2015.03.025","article-title":"Transcutaneous vagus nerve stimulation modulates default mode network in major depressive disorder","volume":"79","author":"Fang","year":"2016","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.neurom.2021.10.021_bib33","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jad.2016.08.003","article-title":"Transcutaneous vagus nerve stimulation modulates amygdala functional connectivity in patients with depression","volume":"205","author":"Liu","year":"2016","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.neurom.2021.10.021_bib34","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jpsychires.2017.12.018","article-title":"Frequency-dependent functional connectivity of the nucleus accumbens during continuous transcutaneous vagus nerve stimulation in major depressive disorder","volume":"102","author":"Wang","year":"2018","journal-title":"J\u00a0Psychiatr Res"},{"key":"10.1016\/j.neurom.2021.10.021_bib35","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.brs.2018.01.006","article-title":"A\u00a0distinct biomarker of continuous transcutaneous vagus nerve stimulation treatment in major depressive disorder","volume":"11","author":"Tu","year":"2018","journal-title":"Brain Stimul"},{"key":"10.1016\/j.neurom.2021.10.021_bib36","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.nicl.2016.12.016","article-title":"Early cortical biomarkers of longitudinal transcutaneous vagus nerve stimulation treatment success in depression","volume":"14","author":"Fang","year":"2017","journal-title":"Neuroimage Clin"},{"key":"10.1016\/j.neurom.2021.10.021_bib37","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1176\/appi.ajp.2014.14070889","article-title":"Citalopram, methylphenidate, or their combination in geriatric depression: a randomized, double-blind, placebo-controlled trial","volume":"172","author":"Lavretsky","year":"2015","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.neurom.2021.10.021_bib38","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.07.027","article-title":"Efficacy and safety of citalopram for the treatment of poststroke depression: a meta-analysis","volume":"27","author":"Cui","year":"2018","journal-title":"J\u00a0Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.neurom.2021.10.021_bib39","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neuropharm.2011.07.036","article-title":"Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders","volume":"62","author":"Sanacora","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neurom.2021.10.021_bib40","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.neuron.2019.03.013","article-title":"Altered connectivity in depression: GABA and glutamate neurotransmitter deficits and reversal by novel treatments","volume":"102","author":"Duman","year":"2019","journal-title":"Neuron"},{"issue":"suppl E1","key":"10.1016\/j.neurom.2021.10.021_bib41","first-page":"4","article-title":"Relationship of neurotransmitters to the symptoms of major depressive disorder","volume":"69","author":"Nutt","year":"2008","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.neurom.2021.10.021_bib42","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41398-018-0183-x","article-title":"Diagnosis of major depressive disorder based on changes in multiple plasma neurotransmitters: a targeted metabolomics study","volume":"8","author":"Pan","year":"2018","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.neurom.2021.10.021_bib43","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3760\/cma.j.issn.0366-6999.20131511","article-title":"An alternative therapy for drug-resistant epilepsy: transcutaneous auricular vagus nerve stimulation","volume":"127","author":"Rong","year":"2014","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.neurom.2021.10.021_bib44","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/1472-6882-12-255","article-title":"Transcutaneous vagus nerve stimulation for the treatment of depression: a study protocol for a double blinded randomized clinical trial","volume":"12","author":"Rong","year":"2012","journal-title":"BMC Complement Altern Med"},{"key":"10.1016\/j.neurom.2021.10.021_bib45","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/1472-6882-14-203","article-title":"Effect of transcutaneous auricular vagus nerve stimulation on impaired glucose tolerance: a pilot randomized study","volume":"14","author":"Huang","year":"2014","journal-title":"BMC Complement Altern Med"},{"key":"10.1016\/j.neurom.2021.10.021_bib46","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1042\/CS20090264","article-title":"Effects of auricular electrical stimulation on vagal activity in healthy men: evidence from a three-armed randomized trial","volume":"118","author":"La Marca","year":"2010","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.neurom.2021.10.021_bib47","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.yebeh.2014.08.005","article-title":"A\u00a0controlled trial of transcutaneous vagus nerve stimulation for the treatment of pharmacoresistant epilepsy","volume":"39","author":"Aihua","year":"2014","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.neurom.2021.10.021_bib48","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1471-2202-14-85","article-title":"The auriculo-vagal afferent pathway and its role in seizure suppression in rats","volume":"14","author":"He","year":"2013","journal-title":"BMC Neurosci"},{"key":"10.1016\/j.neurom.2021.10.021_bib49","first-page":"447","article-title":"[Effects of transcutaneous electrostimulation of auricular concha at different stimulating frequencies and duration on acute seizures in epilepsy rats]","volume":"37","author":"Wang","year":"2012","journal-title":"Zhen Ci Yan Jiu"},{"key":"10.1016\/j.neurom.2021.10.021_bib50","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1177\/0269881115581093","article-title":"Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2008 British Association for Psychopharmacology guidelines","volume":"29","author":"Cleare","year":"2015","journal-title":"J\u00a0Psychopharmacol"},{"key":"10.1016\/j.neurom.2021.10.021_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/157340010790596571","article-title":"Expectancy and the treatment of depression: a review of experimental methodology and effects on patient outcome","volume":"6","author":"Rutherford","year":"2010","journal-title":"Curr Psychiatry Rev"},{"key":"10.1016\/j.neurom.2021.10.021_bib52","series-title":"StatPearls","article-title":"Citalopram","author":"Shoar","year":"2021"},{"key":"10.1016\/j.neurom.2021.10.021_bib53","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","article-title":"Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis","volume":"391","author":"Cipriani","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.neurom.2021.10.021_bib54","first-page":"CD006534","article-title":"Citalopram versus other anti-depressive agents for depression","volume":"7","author":"Cipriani","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.neurom.2021.10.021_bib55","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41398-019-0507-5","article-title":"Metabolomic signature of exposure and response to citalopram\/escitalopram in depressed outpatients","volume":"9","author":"Bhattacharyya","year":"2019","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.neurom.2021.10.021_bib56","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000069738","article-title":"The problem of the placebo response in clinical trials for psychiatric disorders: culprits, possible remedies, and a novel study design approach","volume":"72","author":"Fava","year":"2003","journal-title":"Psychother Psychosom"},{"key":"10.1016\/j.neurom.2021.10.021_bib57","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1371\/journal.pmed.0050045","article-title":"Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration","volume":"5","author":"Kirsch","year":"2008","journal-title":"PLoS Med"},{"key":"10.1016\/j.neurom.2021.10.021_bib58","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jad.2015.08.025","article-title":"Decreased platelet 5-hydroxytryptamin (5-HT) levels: a response to antidepressants","volume":"187","author":"Li","year":"2015","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.neurom.2021.10.021_bib59","article-title":"Transcutaneous auricular vagus nerve stimulation triggers melatonin secretion and is antidepressive in Zucker diabetic fatty rats","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neurom.2021.10.021_bib60","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/ijnp\/pyx056","article-title":"Dopamine system dysregulation in major depressive disorders","volume":"20","author":"Belujon","year":"2017","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.neurom.2021.10.021_bib61","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00228-009-0650-7","article-title":"The change in plasma GABA, glutamine and glutamate levels in fluoxetine- or S-citalopram-treated female patients with major depression","volume":"65","author":"K\u00fc\u00e7\u00fckibrahimo\u011flu","year":"2009","journal-title":"Eur J Clin Pharmacol"}],"container-title":["Neuromodulation: Technology at the Neural Interface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094715921063960?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094715921063960?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T16:02:38Z","timestamp":1726416158000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094715921063960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S1094715921063960"],"URL":"https:\/\/doi.org\/10.1016\/j.neurom.2021.10.021","relation":{},"ISSN":["1094-7159"],"issn-type":[{"value":"1094-7159","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative Effectiveness of Transcutaneous Auricular Vagus Nerve Stimulation vs Citalopram for Major Depressive Disorder: A Randomized Trial","name":"articletitle","label":"Article Title"},{"value":"Neuromodulation: Technology at the Neural Interface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurom.2021.10.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc. on behalf of the International Neuromodulation Society.","name":"copyright","label":"Copyright"}]}}